BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24958819)

  • 1. Clinical tumor sequencing: an incidental casualty of the American College of Medical Genetics and Genomics recommendations for reporting of incidental findings.
    Parsons DW; Roy A; Plon SE; Roychowdhury S; Chinnaiyan AM
    J Clin Oncol; 2014 Jul; 32(21):2203-5. PubMed ID: 24958819
    [No Abstract]   [Full Text] [Related]  

  • 2. Recommendations for returning genomic incidental findings? We need to talk!
    Burke W; Antommaria AH; Bennett R; Botkin J; Clayton EW; Henderson GE; Holm IA; Jarvik GP; Khoury MJ; Knoppers BM; Press NA; Ross LF; Rothstein MA; Saal H; Uhlmann WR; Wilfond B; Wolf SM; Zimmern R
    Genet Med; 2013 Nov; 15(11):854-9. PubMed ID: 23907645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
    Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
    Genet Med; 2023 Aug; 25(8):100866. PubMed ID: 37347242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
    Miller DT; Lee K; Gordon AS; Amendola LM; Adelman K; Bale SJ; Chung WK; Gollob MH; Harrison SM; Herman GE; Hershberger RE; Klein TE; McKelvey K; Richards CS; Vlangos CN; Stewart DR; Watson MS; Martin CL;
    Genet Med; 2021 Aug; 23(8):1391-1398. PubMed ID: 34012069
    [No Abstract]   [Full Text] [Related]  

  • 5. ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
    Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
    Genet Med; 2022 Jul; 24(7):1407-1414. PubMed ID: 35802134
    [No Abstract]   [Full Text] [Related]  

  • 6. Point-counterpoint. Ethics and genomic incidental findings.
    McGuire AL; Joffe S; Koenig BA; Biesecker BB; McCullough LB; Blumenthal-Barby JS; Caulfield T; Terry SF; Green RC
    Science; 2013 May; 340(6136):1047-8. PubMed ID: 23686340
    [No Abstract]   [Full Text] [Related]  

  • 7. Returning incidental findings in African genomics research.
    Wonkam A; de Vries J
    Nat Genet; 2020 Jan; 52(1):17-20. PubMed ID: 31768070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
    Green RC; Berg JS; Grody WW; Kalia SS; Korf BR; Martin CL; McGuire AL; Nussbaum RL; O'Daniel JM; Ormond KE; Rehm HL; Watson MS; Williams MS; Biesecker LG;
    Genet Med; 2013 Jul; 15(7):565-74. PubMed ID: 23788249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACMG recommendations on incidental findings are flawed scientifically and ethically.
    Holtzman NA
    Genet Med; 2013 Sep; 15(9):750-1. PubMed ID: 24008255
    [No Abstract]   [Full Text] [Related]  

  • 10. Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium.
    Berg JS; Amendola LM; Eng C; Van Allen E; Gray SW; Wagle N; Rehm HL; DeChene ET; Dulik MC; Hisama FM; Burke W; Spinner NB; Garraway L; Green RC; Plon S; Evans JP; Jarvik GP;
    Genet Med; 2013 Nov; 15(11):860-7. PubMed ID: 24195999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The implications of familial incidental findings from exome sequencing: the NIH Undiagnosed Diseases Program experience.
    Lawrence L; Sincan M; Markello T; Adams DR; Gill F; Godfrey R; Golas G; Groden C; Landis D; Nehrebecky M; Park G; Soldatos A; Tifft C; Toro C; Wahl C; Wolfe L; Gahl WA; Boerkoel CF
    Genet Med; 2014 Oct; 16(10):741-50. PubMed ID: 24784157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes of genetics professionals toward the return of incidental results from exome and whole-genome sequencing.
    Yu JH; Harrell TM; Jamal SM; Tabor HK; Bamshad MJ
    Am J Hum Genet; 2014 Jul; 95(1):77-84. PubMed ID: 24975944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Incidental Findings in Clinical Genomic Sequencing.
    Krier JB; Green RC
    Curr Protoc Hum Genet; 2015 Oct; 87():9.23.1-9.23.16. PubMed ID: 26439717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
    ACMG Board of Directors
    Genet Med; 2019 Jul; 21(7):1467-1468. PubMed ID: 31019278
    [No Abstract]   [Full Text] [Related]  

  • 15. Minimizing liability risks under the ACMG recommendations for reporting incidental findings in clinical exome and genome sequencing.
    Evans BJ
    Genet Med; 2013 Dec; 15(12):915-20. PubMed ID: 24030435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidental findings in clinical genomics: a clarification.
    American College of Medical Genetics and Genomics
    Genet Med; 2013 Aug; 15(8):664-6. PubMed ID: 23828017
    [No Abstract]   [Full Text] [Related]  

  • 17. American College of Medical Genetics and Genomics: standards and guidelines for documenting suspected consanguinity as an incidental finding of genomic testing.
    Rehder CW; David KL; Hirsch B; Toriello HV; Wilson CM; Kearney HM
    Genet Med; 2013 Feb; 15(2):150-2. PubMed ID: 23328890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Not-so-incidental findings: the ACMG recommendations on the reporting of incidental findings in clinical whole genome and whole exome sequencing.
    Allyse M; Michie M
    Trends Biotechnol; 2013 Aug; 31(8):439-41. PubMed ID: 23664778
    [No Abstract]   [Full Text] [Related]  

  • 19. Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG).
    Li MM; Chao E; Esplin ED; Miller DT; Nathanson KL; Plon SE; Scheuner MT; Stewart DR;
    Genet Med; 2020 Jul; 22(7):1142-1148. PubMed ID: 32321997
    [No Abstract]   [Full Text] [Related]  

  • 20. Current controversies in prenatal diagnosis 2: The 59 genes ACMG recommends reporting as secondary findings when sequencing postnatally should be reported when detected on fetal (and parental) sequencing.
    Amor DJ; Chitty LS; Van den Veyver IB
    Prenat Diagn; 2020 Dec; 40(12):1508-1514. PubMed ID: 32091628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.